Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 09 July 2013 | By Alexander Gaffney, RAC,
The European Medicines Agency (EMA) has announced the formation of a new advisory council known as the Healthcare Professionals' Working Party (HCPWP), which is intended to provide regulators with the perspective of healthcare professionals on the regulation of medicinal products.
The announcement, made on 9 July 2013, notes that regulators had previously relied on healthcare professionals' advice on an informal basis through a working group within its Committee for Medicinal Products for Human use (CHMP).
However, now EMA has "formalized" the group, giving it more of an ability to interact across committees, including the CHMP, the Pharmacovigilance Risk Assessment Committee (PRAC), the Committee on Herbal Medicinal Products (HMPC), the Committee for Orphan Medicinal Products (COMP), the Paediatric Committee (PDCO) and the Committee for Advanced Therapies (CAT).
"The working party will provide continuous input on the evaluation and safety monitoring of medicines throughout their lifecycle," EMA explained in a statement, adding that the group plans to meet quarterly.
The HCPWP has six principal tasks:
The HCPWP will be composed of professionals from at least 18 societies, including those representing AIDS clinians, pharmacologists, diabetes, hospital pharmacists, urology, internists, neurologists, oncologists, cardiologists, endocrinologists, nurses, radiologists, and more.
38 members are currently involved in the group. A similar arrangement is in place with patients and consumers through a Patient's and Consumers' Working Party (PCWP), EMA noted.
Regulatory Focus newsletters
All the biggest regulatory news and happenings.